Paragon Health Institute Icon White

Joel Zinberg Quoted in The Washington Times

Prescription medicine on a $100 bill
Director at Public Health and American Well-Being Initiative
Joel M. Zinberg, M.D., J.D. is the Director of the Public Health and American Well-Being Initiative at Paragon Health Institute, and a senior fellow with the Competitive Enterprise Institute. A native New Yorker, he recently completed two years as General Counsel and Senior Economist at the Council of Economic Advisers in the Executive Office of the President.

On December 29, 2023, Paragon’s Dr. Joel Zinberg was quoted in The Washington Times article “Biden evokes patent power to force lower drug prices; heeds voter complaints over innovation costs”

From the article:

Dr. Joel Zinberg, a senior fellow at the Competitive Enterprise Institute and director of the Paragon Health Institute’s Public Health and American Well-Being Initiative, said the high prices of some drugs reflect the cost of innovation and cheaper generic versions eventually reach the market without government intervention. Americans often pay higher prices but have earlier access to the drugs than patients in other countries and later pay less than in other countries for generics.

He cited American-made HIV and hepatitis C drugs that have decreased considerably in cost just a few years after their introduction.

“Within that initial time frame for some of these innovative drugs, the prices are higher here,” Dr. Zinberg said. “But on the back end, we’ve gotten the benefit of those innovative drugs at much lower prices.”

The full article can be found in The Washington Times.

Related Content


Sign up now for your health policy updates.

This field is for validation purposes and should be left unchanged.